SCHEMBL6733348

SCHEMBL6733348

O=C(O)c1c[nH]c2c(Cl)ccnc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 3/20 0.69
KDM5A P29375 2/20 0.69
CSNK2A2 P19784 3/20 0.47
CSNK2B P67870 3/20 0.47
CSNK2A1 P68400 3/20 0.47
TET2 Q6N021 1/20 0.47
TET1 Q8NFU7 1/20 0.47
F7 P08709 1/20 0.44
F3 P13726 1/20 0.44
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 3/20 0.40
CYP1A2 P05177 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4A O75164 2/20 0.39
RAB9A P51151 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
HIF1AN Q9NWT6 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NR4A2 P43354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1472608 0.87 KDM5A (0.56) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1
SCHEMBL21042568 0.85 KDM5A (0.54) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1
Potassium Ion SCHEMBL1763260 0.82 KDM5A (0.51) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1
SCHEMBL12215399 0.82 KDM5A (0.51) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1
SCHEMBL16157363 0.81 KDM5A (1.00) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1
SCHEMBL1763380 0.79 KDM5A (0.48) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1
SCHEMBL29956210 0.77 KDM5A (0.65) KDM4CKDM5ATET2TET1SMN1; SMN2
SCHEMBL21509475 0.76 KDM4C (0.55) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1
SCHEMBL2080225 0.76 KDM5A (0.47) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1
SCHEMBL17818839 0.75 CSNK2A1 (0.52) KDM4CKDM5ACSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed